Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter to the Shareholders March 2008

I am under the impression the entire letter is not posted IMO.....

<Jim leaves the Company having outlined a plan to transition the Company from sole reliance on our MMP licensing revenues into an operating company with sustainable growth, profitability and increased shareholder value.>

That just gave me the impression, that period of time was a waste IMO.....

<Additionally, the Board and I are launching a campaign to replace the two open Board seats >

In addition to the CEO or not? It could be a dumb question on my past......

Share
New Message
Please login to post a reply